Prevalence and use of cannabis products and routes of administration among youth and young adults in Canada and the United States: A systematic review.
Prevalence and use of cannabis products and routes of administration among youth and young adults in Canada and the United States: A systematic review.
复制标题
加拿大和美国青少年和年轻人大麻产品的流行和使用以及给药途径：系统评价。
DOI：
10.1016/j.addbeh.2022.107258
复制
发表时间：
2022
影响因子：
4.4
通讯作者：
D. Hammond
中科院分区：
文献类型：
--
作者：
E. Wadsworth;S. Craft;R. Calder;D. Hammond
背景本系统综述旨在总结加拿大和美国(US)青少年和青壮年使用的给药途径和大麻产品的流行率的文献。方法检索2020年4月和2021年2月的5个学术数据库。如果是一项基于人群的定量观察性研究，描述了大麻产品或给药途径在加拿大或美国的年轻人中的流行率，则纳入同行评议的文章。使用Hoy和他的同事的偏差风险评估工具来评估偏差风险。结果共纳入26项研究，涉及以下给药途径：吸食(n=16)、蒸发(n=21)、轻拍(n=3)、口服(n=13)、外用(n=1)；以及产品：干花(n=2)和浓缩物(n=8)。吸烟在年轻人和年轻人中的流行率最高；然而，吸烟率似乎随着时间的推移而下降。相反，蒸发的流行率似乎随着时间的推移而增加。较少的研究集中在口服或涂抹大麻，但那些确实报告了在最近的大麻消费者中大约三分之一的流行率估计。讨论大麻给药途径的异质性限制了我们整理平均流行率估计的能力。在非医用大麻合法的司法管辖区，政策制定者应就每种产品和给药途径向青年提供指导和教育。这项研究的其他资金由加拿大卫生研究所提供(PJT-153342)。目前的审查已在Propero注册(CRD42020169275)。
BackgroundThe current systematic review aimed to summarize the literature on the prevalence of routes of administration and cannabis products used among youth and young adults in Canada and the United States (US).MethodsFive academic databases were searched in April 2020 and February 2021. Peer-reviewed articles were included if they were a population-based quantitative observational study describing the prevalence of a cannabis product or route of administration among youth and young adults in Canada or the US. Risk of bias was assessed using Hoy and colleagues’ risk of bias assessment tool. A narrative review was conducted.ResultsTwenty-six studies were identified for the following routes of administration: smoking (n = 16), vaping (n = 21), dabbing (n = 3), oral (n = 13), topical (n = 1); and products: dried flower (n = 2), and concentrates (n = 8). Smoking had the highest prevalence rates among youth and young adults; however, rates of use appeared to reduce over time. Conversely, prevalence of vaping appeared to increase over time. Fewer studies focused on oral or dabbed cannabis but those that did reported prevalence estimates of approximately a third among recent cannabis consumers.DiscussionThe heterogeneity of cannabis routes of administration restricted our ability to collate average prevalence estimates. In jurisdictions where non-medical cannabis is legal, policymakers should provide guidance and education to youth on each type of product and routes of administration.OtherFunding for this study was provided by a Canadian Institutes of Health Research (PJT-153342). The current review was registered with PROSPERO (CRD42020169275).
影响因子：
4.2
作者：
Krauss MJ;Sowles SJ;Sehi A;Spitznagel EL;Berg CJ;Bierut LJ;Cavazos-Rehg PA
通讯作者：
Cavazos-Rehg PA
影响因子：
4.4
作者：
Krauss, Melissa J.;Rajbhandari, Biva;Cavazos-Rehg, Patricia
通讯作者：
Cavazos-Rehg, Patricia